Namesake of Charlotte’s Web CBD Strain, Charlotte Figi, Dies Age 13 of COVID-19

Charlotte Figi pushed the world towards greater acceptance for the cannabis plant and the potential it holds. She was at the forefront of the medical cannabis and CBD sphere, and will be remembered as a pioneer and inspiration.

Charlotte Figi

Colorado native, Charlotte Figi passed away at the age of 13 with COVID-19. The wonderful young girl who inspired the creation of the low THC, high CBD strain ‘Charlotte’s Web’ passed away on Tuesday after facing complications with the virus. 

Charlotte suffered from Dravet syndrome, and by the age of 3 she was suffering from up to 300 grand mal seizures a week. Her parents exhausted all pharmaceutical options until they heard about the potential of medical cannabis. They then sought the help of the Stanley Brothers, who were willing to help and eventually engineered Charlotte’s Web CBD in 2011. Once Charlotte started consuming this CBD oil, her seizures decreased to just 2-3 a month and changed her life as she knew it. 

The creation of this single variety started a cannabis craze that hadn’t been seen before. People’s opinions began to change and many became more accepting of the plant in one shape or form. Hundreds of families started travelling to Colorado, seeking alternative treatments for various health conditions after Colorado legalised medical cannabis. 

A family friend took to Facebook on Tuesday and posted: “Charlotte is no longer suffering. She is seizure-free forever.” The family has also asked for privacy at this team. 

The shocking news has led the global cannabis community to mourn for the girl who changed the cannabis landscape forever. Her story will not be forgotten and she will live on in the hearts and minds of the cannabis community. 

We raise our joints today and give a moment of silence for this brave girl & extend our deepest and most heartfelt condolences to Charlotte’s family and friends.

Photo by Matt Nager
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments